FDA approves Hemlibra to prevent bleeding in patients with haemophilia A
Hemlibra has been approved to prevent the frequency of bleeding episodes in patients who have developed FVIII inhibitors...
List view / Grid view
Hemlibra has been approved to prevent the frequency of bleeding episodes in patients who have developed FVIII inhibitors...
Cell-weighing technique may predict which therapies a patient is most sensitive or resistant to...
Quotient Clinical, the drug development services organisation, announces its renaming to Quotient Sciences (Quotient), following the acquisitions of Co-Formulate, QS Pharma and SeaView Research...
Studies show cell-based treatment is safe in patients with dry macular degeneration, with one showing improved vision...
The FDA has approved the first drug in the U.S. with a digital ingestion tracking system that records that the medication was taken...
In vitro study verifies method for remotely triggering release of cancer drugs...
Company establishes its presence in South Korea...
The effect of combining clinically used drugs for the treatment of colon cancer analysed using novel open source software...
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza...
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects...
Infants with SMA are more likely to show gains in motor function and survive without assisted support when treated with nusinersen...
A topical gel made from a class of common blood pressure medications has been found to accelerate the healing process of chronic skin wounds...
Scientists have developed self-assembling polymer molecules - an advance that could improve the delivery of toxic drugs to tumours...
Researchers have designed synthetic beta cells that secrete insulin in response to high blood sugar...
Crisaborole and dupilumab approved for atopic dermatitis…